Page 111 - ITPS-8-3

INNOSC Theranostics and
Pharmacological Sciences Persistent olfactory and gustatory dysfunctions caused by COVID-19 vaccination

complications and in clinical trials targeting persistent 5. Riad A, Põld A, Kateeb E, Attia S. Oral adverse events
post-COVID-19 vaccine disorders. following COVID-19 vaccination: Analysis of VAERS
reports. Front Public Health. 2022;10:952781.
Acknowledgment doi: 10.3389/fpubh.2022.952781

None. 6. Zamzami OS, Kabli AF, Alhothali AS, et al. Post-COVID-19
vaccine parosmia: A case report. Cureus. 2021;13(12):e20292.
Funding
doi: 10.7759/cureus.20292
None.
7. Fantin F, Frosolini A, Tundo I, et al. A singular case of
Conflict of interests hyposmia and transient audiovestibular post-vaccine
disorders: Case report and literature review. Transl Neurosci.
The authors declare that they have no competing interests. 2022;13(1):349-353.
Author contributions doi: 10.1515/tnsci-2022-0250
Conceptualization: All authors 8. Ogata S, Ishii Y, Asano K, et al. Sensory ataxic Guillain-
Investigation: All authors Barré syndrome with dysgeusia after mRNA COVID-19
vaccination. Intern Med. 2022;61(11):1757-1760.
Writing – original draft: All authors
Writing – review & editing: All authors doi: 10.2169/internalmedicine.8967-21
Ethics approval and consent to participate 9. Barter K, Bagnato F. Olfactory hallucinations following
COVID-19 vaccination. Fed Pract. 2023;40(9):1-3.
This study was done in accordance with the revised Helsinki doi: 10.12788/fp.0410
Declaration (2013) and its amendments and approved by
the local ethics committee of Assiut University Hospitals, 10. Shin B, Tam AC. COVID-19 mRNA Vaccine Linked to
Assiut, Egypt (ID: AUFM_COVID_00020). Dysgeusia and Hyposmia: A Case Report. Henry Ford Jackson
Hospital Research Symposium; 2024. Available from:
Consent for publication https://scholarlycommons.henryford.com/cgi/viewcontent.
cgi?article=1011&context=hfjhrs2024 [Last accessed on
We declare that we have obtained written informed consent 2025 Jan 15].
from all patients for releasing their data and the results of 11. Keir G, Maria NI, Kirsch CF. Unique imaging findings
their evaluations in this paper. of neurologic phantosmia following pfizer-biontech

Availability of data COVID-19 vaccination: A case report. Top Magn Reson
Imaging. 2021;30(3):133-137.
Data supporting the findings of this study are available doi: 10.1097/RMR.0000000000000287
from the corresponding author upon reasonable request.
12. Hamed SA, Ahmed MA. The effectiveness of cerebrolysin,
References a multi-modal neurotrophic factor, for treatment of post-
COVID-19 persistent olfactory, gustatory and trigeminal
1. Francis AI, Ghany S, Gilkes T, Umakanthan S. Review of chemosensory dysfunctions: A randomized clinical trial.
COVID-19 vaccine subtypes, efficacy and geographical Expert Rev Clin Pharmacol. 2023;16(12):1261-1276.
distributions. Postgrad Med J. 2022;98(1159):389-394.
doi: 10.1080/17512433.2023.2282715
doi: 1136/postgradmedj-2021-140654
13. Hamed SA, Kamal-Eldeen EB, Ahmed MA. Evaluation of
2. COVID-19 mRNA Pfizer- BionTech Vaccine Analysis Print; children and adults with post-COVID-19 persistent smell,
2021. Available from: https://assets.publishing.service.gov. taste and trigeminal chemosensory disorders: A hospital
uk/media/628e3cd3d3bf7f1f3b19efd2/foi-21-1345-22.pdf based study. World J Clin Pediatr. 2023;12(3):133-150.
[Last accessed on 2021 Apr 30].
doi: 10.5409/wjcp.v12.i3.133
3. COVID-19 AstraZeneca Vaccine Analysis Print; 2021.
Available from: https://assets.publishing.service.gov. 14. Hamed SA. Post-COVID-19 persistent olfactory,
uk/media/65f16ea8133c220011cd39e0/foi-23-670-pdf- gustatory, and trigeminal chemosensory disorders:
attachment--17-.pdf [Last accessed on 2021 Dec 04]. Definitions, mechanisms, and potential treatments. World J
Otorhinolaryngol. 2023;10(2):4-22.
4. Klugar M, Riad A, Mekhemar M, et al. Side effects of mRNA-
based and viral vector-based COVID-19 vaccines among doi: 10.5319/wjo.v10.i2.4
German healthcare workers. Biology (Basel). 2021;10(8):752.
15. Lee WS, Wheatley AK, Kent SJ, Dekosky BJ. Antibody-
doi: 10.3390/biology10080752 dependent enhancement and SARS-CoV-2 vaccines and

Volume 8 Issue 3 (2025) 105 doi: 10.36922/ITPS025140020